Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Sep 1;182(3):639–641. doi: 10.1084/jem.182.3.639

Antigen presentation to cytotoxic T lymphocytes in vivo

PMCID: PMC2192154  PMID: 7650475

Full Text

The Full Text of this article is available as a PDF (363.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold D., Faath S., Rammensee H., Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med. 1995 Sep 1;182(3):885–889. doi: 10.1084/jem.182.3.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bachmann M. F., Kündig T. M., Freer G., Li Y., Kang C. Y., Bishop D. H., Hengartner H., Zinkernagel R. M. Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol. 1994 Sep;24(9):2228–2236. doi: 10.1002/eji.1830240944. [DOI] [PubMed] [Google Scholar]
  3. Bevan M. J. Antigen recognition. Class discrimination in the world of immunology. Nature. 1987 Jan 15;325(6101):192–194. doi: 10.1038/325192b0. [DOI] [PubMed] [Google Scholar]
  4. Bevan M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med. 1976 May 1;143(5):1283–1288. doi: 10.1084/jem.143.5.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bevan M. J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol. 1976 Dec;117(6):2233–2238. [PubMed] [Google Scholar]
  6. Carbone F. R., Bevan M. J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med. 1990 Feb 1;171(2):377–387. doi: 10.1084/jem.171.2.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Debrick J. E., Campbell P. A., Staerz U. D. Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol. 1991 Nov 1;147(9):2846–2851. [PubMed] [Google Scholar]
  8. Fossum S., Rolstad B. The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes. Eur J Immunol. 1986 Apr;16(4):440–450. doi: 10.1002/eji.1830160422. [DOI] [PubMed] [Google Scholar]
  9. Gasser D. L., Silvers W. K. Genetics and immunology of sex-linked antigens. Adv Immunol. 1972;15:215–247. doi: 10.1016/s0065-2776(08)60686-0. [DOI] [PubMed] [Google Scholar]
  10. Germain R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994 Jan 28;76(2):287–299. doi: 10.1016/0092-8674(94)90336-0. [DOI] [PubMed] [Google Scholar]
  11. Gooding L. R., Edwards C. B. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol. 1980 Mar;124(3):1258–1262. [PubMed] [Google Scholar]
  12. Gordon R. D., Mathieson B. J., Samelson L. E., Boyse E. A., Simpson E. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen. J Exp Med. 1976 Sep 1;144(3):810–820. doi: 10.1084/jem.144.3.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hill A., Ploegh H. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):341–343. doi: 10.1073/pnas.92.2.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Huang A. Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 1994 May 13;264(5161):961–965. doi: 10.1126/science.7513904. [DOI] [PubMed] [Google Scholar]
  15. Inaba K., Inaba M., Naito M., Steinman R. M. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med. 1993 Aug 1;178(2):479–488. doi: 10.1084/jem.178.2.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K. L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4942–4946. doi: 10.1073/pnas.90.11.4942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kovacsovics-Bankowski M., Rock K. L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 1995 Jan 13;267(5195):243–246. doi: 10.1126/science.7809629. [DOI] [PubMed] [Google Scholar]
  18. Nair S., Buiting A. M., Rouse R. J., Van Rooijen N., Huang L., Rouse B. T. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol. 1995 Apr;7(4):679–688. doi: 10.1093/intimm/7.4.679. [DOI] [PubMed] [Google Scholar]
  19. Pfeifer J. D., Wick M. J., Roberts R. L., Findlay K., Normark S. J., Harding C. V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 1993 Jan 28;361(6410):359–362. doi: 10.1038/361359a0. [DOI] [PubMed] [Google Scholar]
  20. Rammensee H. G., Falk K., Rötzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol. 1993;11:213–244. doi: 10.1146/annurev.iy.11.040193.001241. [DOI] [PubMed] [Google Scholar]
  21. Reis e Sousa C., Stahl P. D., Austyn J. M. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med. 1993 Aug 1;178(2):509–519. doi: 10.1084/jem.178.2.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SNELL G. D., WHEELER N., AARON M. A new method of typing inbred strains of mice for histocompatibility antigens. Transplant Bull. 1957 Jan;4(1):18–21. [PubMed] [Google Scholar]
  23. Schirmbeck R., Böhm W., Reimann J. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur J Immunol. 1994 Sep;24(9):2068–2072. doi: 10.1002/eji.1830240920. [DOI] [PubMed] [Google Scholar]
  24. Srivastava P. K., Old L. J. Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today. 1988 Mar;9(3):78–83. doi: 10.1016/0167-5699(88)91269-8. [DOI] [PubMed] [Google Scholar]
  25. Srivastava P. K., Udono H., Blachere N. E., Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 1994;39(2):93–98. doi: 10.1007/BF00188611. [DOI] [PubMed] [Google Scholar]
  26. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271–296. doi: 10.1146/annurev.iy.09.040191.001415. [DOI] [PubMed] [Google Scholar]
  27. Udono H., Levey D. L., Srivastava P. K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3077–3081. doi: 10.1073/pnas.91.8.3077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Udono H., Srivastava P. K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol. 1994 Jun 1;152(11):5398–5403. [PubMed] [Google Scholar]
  29. Udono H., Srivastava P. K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 1993 Oct 1;178(4):1391–1396. doi: 10.1084/jem.178.4.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ullrich S. J., Robinson E. A., Law L. W., Willingham M., Appella E. A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc Natl Acad Sci U S A. 1986 May;83(10):3121–3125. doi: 10.1073/pnas.83.10.3121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Weidt G., Utermöhlen O., Zerrahn J., Reimann J., Deppert W., Lehmann-Grube F. CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J Immunol. 1994 Sep 15;153(6):2554–2561. [PubMed] [Google Scholar]
  32. Zhou F., Rouse B. T., Huang L. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J Immunol. 1992 Sep 1;149(5):1599–1604. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES